<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Presentations by international experts from old and new worlds bordering the Atlantic Ocean revealed surprising similarities with respect to the diagnosis and management of patients with <z:e sem="disease" ids="C0810300" disease_type="Disease or Syndrome" abbrv="">upper gastrointestinal disorders</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>It was agreed that <z:hpo ids='HP_0005202'>Helicobacter pylori infection</z:hpo> continues to play a key role in gastroduodenal disease and has a great impact on clinical management </plain></SENT>
<SENT sid="2" pm="."><plain>However, testing and treatment strategies vary in patients affected by <z:e sem="disease" ids="C0267167" disease_type="Disease or Syndrome" abbrv="">functional dyspepsia</z:e> and those receiving <z:chebi fb="2" ids="35475">nonsteroidal anti-inflammatory drug</z:chebi> (<z:chebi fb="1" ids="35475">NSAID</z:chebi>) therapy including aspirin </plain></SENT>
<SENT sid="3" pm="."><plain>Among patients with <z:e sem="disease" ids="C0017168" disease_type="Disease or Syndrome" abbrv="GERD">gastro-oesophageal reflux disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e>), it was clear that we need to re-evaluate the validity of the classical concept of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> as a progressive spectrum and instead focus on the pathophysiologic mechanisms responsible for producing the common symptom of heartburn and complications that occur in the three principle subsets of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> patients: those with endoscopic negative reflux disease, <z:e sem="disease" ids="C0267055" disease_type="Disease or Syndrome" abbrv="">erosive oesophagitis</z:e> and <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>In addition, we need to be increasingly aware of the concept of extra-oesophageal manifestations of <z:e sem="disease" ids="C0017168" disease_type="Disease or Syndrome" abbrv="GERD">gastro-oesophageal reflux</z:e> and the fact that <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> in adults often originates in childhood </plain></SENT>
<SENT sid="5" pm="."><plain>In <z:hpo ids='HP_0000001'>all</z:hpo> these <z:e sem="disease" ids="C0017178" disease_type="Disease or Syndrome" abbrv="">gastrointestinal disorders</z:e>, <z:chebi fb="0" ids="49200">proton pump inhibitor</z:chebi> therapy has become the common thread either as a diagnostic tool or an effective short-term or long-term management strategy </plain></SENT>
</text></document>